MIT and Harvard spinouts will be a focal point for investment from the secnd industrial tech-oriented vehicle launched by Anzu Partners.

AI2's new pre-seed fund will help create 12 new spinouts in fields such as deep learning, computer vision and natural language processing.

University of Pittsburgh Medical Center’s venture arm has allocated $1bn to drugs, diagnostics and devices development, including a $200m partnership with the university.

Weizmann Institute of Science has become the latest academic research institution to join forces with Deerfield Management for a drug discovery program.

Four Points Innovation has been formed with $130m in funding to nurture Duke drug discovery research, in the latest such move by Deerfield Management.

Ohio State University has signed up to a spinout-focused life sciences venture vehicle run by regional firm Rev1 Ventures that stands at three times the size of its precursor.

A2A has formed a corporate venturing arm with $78m in funding, including a commitment from Polytechnic University of Milan’s university venture fund Poli360.

Operator Collective’s inaugural vehicle secured 100 LPs including two universities to back business-to-business enterprises aligned with its diversity ethos.

Emory University's endowment fund was among the LPs that chipped in for the venture capital firm’s Continuum I fund, which has closed at $56.6m.

A group of private investors led by drug development executive An LuFan have seeded a fund to drive healthcare research from South Australia's academic sector.